Consumers have flocked online for cheaper alternatives to name brand obesity drugs. JDawnInk/Digital Vision Vectors/Getty Images hide caption toggle caption…
Read More »Wegovy
Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.…
Read More »The Trump administration on Friday rejected a Biden plan that would have required Medicare and Medicaid to cover obesity drugs…
Read More »Amy Schumer is keeping people updated on her health. The 43-year-old comedian informed fans about her experience with taking an…
Read More »It’s easy to make a medical case for blockbuster weight loss drugs like Wegovy and Zepbound, which have been shown…
Read More »Key Takeaways Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients…
Read More »Key Takeaways Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic…
Read More »KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker’s better-than-estimated quarterly…
Read More »Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of…
Read More »